Upgrade to SI Premium - Free Trial

Vaxcyte, Inc. (PCVX) Misses Q3 EPS by 32c

November 4, 2025 5:54 PM

Vaxcyte, Inc. (NASDAQ: PCVX) reported Q3 EPS of ($1.56), $0.32 worse than the analyst estimate of ($1.24).

For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.

Categories

Earnings